1	Permanent	permanent	_	_	_	_	_	_	_
2	occupancy	occupancy	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
7	virus	virus	_	_	_	_	_	_	_
8	type	type	_	_	_	_	_	_	_
9	1	1	_	_	_	_	_	_	_
10	enhancer	enhancer	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	needed	need	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	persistent	persistent	_	_	_	_	_	_	_
18	viral	viral	_	_	_	_	_	_	_
19	replication	replication	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	monocytes	monocyte	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	work	work	_	_	_	_	_	_	_
3	aimed	aim	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	ascertain	ascertain	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	role	role	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	kappaB-responsive	kappab-responsive	_	_	_	_	_	_	_
10	elements	element	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
15	virus	virus	_	_	_	_	_	_	_
16	type	type	_	_	_	_	_	_	_
17	1	1	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	HIV-1	HIV-1	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	enhancer	enhancer	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	only	only	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	early	early	_	_	_	_	_	_	_
26	initiation	initiation	_	_	_	_	_	_	_
27	but	but	_	_	_	_	_	_	_
28	also	also	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	long-term	long-term	_	_	_	_	_	_	_
31	maintenance	maintenance	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	proviral	proviral	_	_	_	_	_	_	_
34	transcription	transcription	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	cells	cell	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	monocytic	monocytic	_	_	_	_	_	_	_
40	lineage	lineage	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	For	for	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	purpose	purpose	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	used	use	_	_	_	_	_	_	_
7	three	three	_	_	_	_	_	_	_
8	main	main	_	_	_	_	_	_	_
9	approaches	approach	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	first	first	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	abruptly	abruptly	_	_	_	_	_	_	_
6	terminate	terminate	_	_	_	_	_	_	_
7	tumor	tumor	_	_	_	_	_	_	_
8	necrosis	necrosis	_	_	_	_	_	_	_
9	factor-induced	factor-induced	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	binding	bind	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	enhancer	enhancer	_	_	_	_	_	_	_
15	sequences	sequence	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	U1	u1	_	_	_	_	_	_	_
18	monocytic	monocytic	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	using	use	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	short	short	_	_	_	_	_	_	_
24	pulse	pulse	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	exogenous	exogenous	_	_	_	_	_	_	_
27	tumor	tumor	_	_	_	_	_	_	_
28	necrosis	necrosis	_	_	_	_	_	_	_
29	factor	factor	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	resulted	result	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	concomitant	concomitant	_	_	_	_	_	_	_
5	decrease	decrease	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	nuclear	nuclear	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	DNA-binding	dna-binding	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	endogenous	endogenous	_	_	_	_	_	_	_
13	long	long	_	_	_	_	_	_	_
14	terminal	terminal	_	_	_	_	_	_	_
15	repeat	repeat	_	_	_	_	_	_	_
16	transcriptional	transcriptional	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	second	second	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	suppress	suppress	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	permanent	permanent	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	translocation	translocation	_	_	_	_	_	_	_
10	induced	induce	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	HIV-1	HIV-1	_	_	_	_	_	_	_
13	replication	replication	_	_	_	_	_	_	_
14	itself	itself	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	chronically	chronically	_	_	_	_	_	_	_
17	infected	infected	_	_	_	_	_	_	_
18	U937	u937	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	using	use	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	specific	specific	_	_	_	_	_	_	_
24	proteasome	proteasome	_	_	_	_	_	_	_
25	inhibitor	inhibitor	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	Z-LLL-H	Z-LLL-H	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	early	early	_	_	_	_	_	_	_
3	as	as	_	_	_	_	_	_	_
4	2	2	_	_	_	_	_	_	_
5	h	h	_	_	_	_	_	_	_
6	after	after	_	_	_	_	_	_	_
7	addition	addition	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	inhibitor	inhibitor	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	culture	culture	_	_	_	_	_	_	_
14	medium	medium	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	there	there	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	inhibition	inhibition	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	both	both	_	_	_	_	_	_	_
22	constitutive	constitutive	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	HIV-1	HIV-1	_	_	_	_	_	_	_
28	genome	genome	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	third	third	_	_	_	_	_	_	_
3	approach	approach	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	monitor	monitor	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	replication	replication	_	_	_	_	_	_	_
9	competence	competence	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	U937	u937	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	an	an	_	_	_	_	_	_	_
15	infectious	infectious	_	_	_	_	_	_	_
16	HIV-1	HIV-1	_	_	_	_	_	_	_
17	provirus	provirus	_	_	_	_	_	_	_
18	carrying	carry	_	_	_	_	_	_	_
19	point	point	_	_	_	_	_	_	_
20	mutations	mutation	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	kappaB-responsive	kappab-responsive	_	_	_	_	_	_	_
24	elements	element	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	both	both	_	_	_	_	_	_	_
27	long	long	_	_	_	_	_	_	_
28	terminal	terminal	_	_	_	_	_	_	_
29	repeats	repeat	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Compared	compare	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	its	its	_	_	_	_	_	_	_
4	wild-type	wild-type	_	_	_	_	_	_	_
5	counterpart	counterpart	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	mutated	mutate	_	_	_	_	_	_	_
9	provirus	provirus	_	_	_	_	_	_	_
10	showed	show	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	profoundly	profoundly	_	_	_	_	_	_	_
13	decreased	decrease	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	Z-LLL-H-insensitive	z-lll-h-insensitive	_	_	_	_	_	_	_
16	transcriptional	transcriptional	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	replicative	replicative	_	_	_	_	_	_	_
19	activity	activity	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	U937	u937	_	_	_	_	_	_	_
22	monocytes	monocyte	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Together	together	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	our	our	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	indicate	indicate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	occupancy	occupancy	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	viral	viral	_	_	_	_	_	_	_
11	enhancer	enhancer	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	p50/p65	p50/p65	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	heterodimers	heterodimer	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	required	require	_	_	_	_	_	_	_
20	for	for	_	_	_	_	_	_	_
21	ongoing	ongoing	_	_	_	_	_	_	_
22	transcription	transcription	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	integrated	integrate	_	_	_	_	_	_	_
25	HIV	HIV	_	_	_	_	_	_	_
26	provirus	provirus	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	monocytes	monocyte	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	even	even	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	chronically	chronically	_	_	_	_	_	_	_
34	infected	infected	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	permanently	permanently	_	_	_	_	_	_	_
37	producing	produce	_	_	_	_	_	_	_
38	functional	functional	_	_	_	_	_	_	_
39	HIV	HIV	_	_	_	_	_	_	_
40	Tat	Tat	_	_	_	_	_	_	_
41	protein	protein	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	ability	ability	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	HIV-1	HIV-1	_	_	_	_	_	_	_
7	replication	replication	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	activate	activate	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	crucial	crucial	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	intense	intense	_	_	_	_	_	_	_
16	self-perpetuated	self-perpetuated	_	_	_	_	_	_	_
17	viral	viral	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	observed	observe	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	monocytic	monocytic	_	_	_	_	_	_	_
25	lineage	lineage	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

